What to Expect From CVS Health's Next Quarterly Earnings Report CVS Health is scheduled to post its third-quarter results in November, and analysts project a single-digit earnings rise. Barchart · Oct 23
UnitedHealth, CVS, and Kaiser Oppose Medicare Remote Monitoring Vendor Ban While Humana and Blue Cross Back It Major insurers are split over a Medicare plan to bar vendor-run remote monitoring. What it may mean for Medicare Advantage members before open enrollment. Medical Daily · Sep 24
Some Pancreatic Cancer Families Hit Insurance Delays After Rasonque Approval Closed the Drug's Free Early Access Program FDA approval of the pancreatic cancer pill Rasonque closed its free early access program before some insurers were ready to cover it. Medical Daily · Sep 16
Florida Accuses Two of the Nation's Largest Prescription Middlemen of Colluding to Underpay the Pharmacies Filling Prescriptions Florida sued Express Scripts and Prime Therapeutics, alleging a price-fixing deal that forced pharmacies to fill prescriptions at a loss. Medical Daily · Aug 30
One Comment on CVS's Earnings Call Sent the Stock Tumbling CVS Health raised guidance after a strong Q2, but shares fell nearly 5% after executives flagged expected Caremark membership declines in 2026 and a 340B headwind persisting into 2027. MarketBeat · Aug 7
LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs Eli Lilly shares rally on a fresh DTC partnership with CVS Health. A strong Q2 release and impressive future guidance is driving LLY stock higher as well. Barchart · Aug 5
Senators Demand Records from Three Medicare Advantage Insurers on How Post-Hospital Care Gets Denied Blumenthal and Hawley demanded records from UnitedHealthcare, Humana and CVS on AI use in denying post-hospital rehab care for Medicare patients. Medical Daily · Aug 4
Do Wall Street Analysts Like CVS Health Stock? CVS Health has rallied the broader market over the past year, and analysts remain highly optimistic about the stock’s prospects. Barchart · Jul 28
CVS Medicated Wipes Recalled Over Child-Poisoning Risk Parents and caregivers rely on over-the-counter health products to provide safe and effective relief, making product recalls especially concerning. A recent nationwide recall involving CVS Health Medicated Hemorrhoidal Wipes has raised alarms because the packaging does not meet child-resistant safety standards. More than 75,000 boxes have been recalled after regulators… Kids Ain't Cheap · Jul 15
What to Expect From CVS Health's Q2 2026 Earnings Report CVS Health is scheduled to post its second-quarter results in August, and analysts project a single-digit earnings rise. Barchart · Jul 10
Wall Street Turns Bullish on Health Insurers: UNH Surges 5.7% as BofA Upgrades and Morgan Stanley Raises Target to $453 UnitedHealth Group was written off by many investors after five straight sessions of losses. Then Thursday morning arrived — with two simultaneous Wall Street upgrades, easing medical cost data, and a technical setup that had been coiling for a breakout. Here is what changed, what it means for patients, and… Medical Daily · Jun 4
Eli Lilly Wins Back CVS Health, Reverting Novo's Advantage Eli Lilly and Company just secured a big win as it looks to expand GLP-1 access, mending its partnership with top pharmacy benefit manager CVS Health. MarketBeat · Jun 2
Nasdaq Futures Rally on Upbeat AMD Earnings and U.S.-Iran Peace Deal Optimism June Nasdaq 100 E-Mini futures (NQM26) are trending up +1.61% this morning as optimism that the U.S. and Iran are close to a peace agreement, along with upbeat quarterly results and guidance from Advanced Micro Devices, boosted sentiment. Barchart · May 6
CVS Health Stock Outlook: Is Wall Street Bullish or Bearish? Though CVS Health has lagged behind the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects. Barchart · Apr 28
Barchart · Apr 21 Slow-Moving CVS Health (CVS) Stock Could Offer a Surprise for Bullish Options Traders While CVS stock hasn’t exactly enjoyed an auspicious start to the new year, the market appears to have flashed an intriguing setup.
Barchart · Apr 21 Here's What to Expect From CVS Health's Next Earnings Report CVS Health is set to announce its first-quarter earnings next month, and Wall Street expects the company’s EPS to decrease by a single digit.
The Independent UK · Apr 16 Man arrested inside Aetna’s headquarters with AR-style pistol in backpack A man walking into health insurer Aetna’s headquarters with an AR-style pistol in his backpack was detained by security without incident Thursday morning, police said.
International Business Times UK · Mar 13 US Insurance Giant Aetna Agrees to $117.7M Settlement Over Medicare Advantage Fraud Claims Aetna agrees to pay $117.7M to settle federal fraud allegations over inflated Medicare Advantage payments and diagnostic coding practices.
The Independent UK · Mar 5 CVS says it will be forced to pull out of state if new law goes into effect CVS Health has warned it could close all 134 of its pharmacies in Tennessee if a new state bill, Senate Bill 2040, is passed by lawmakers.
The Independent UK · Mar 5 CVS warns it could close all 134 locations in a single state if new bill goes ahead A spokesperson for CVS Health slammed the proposal, branding it ‘bad for Tennessee’
Barchart · Mar 2 How Is CVS Health’s Stock Performance Compared to Other Healthcare Stocks? CVS Health shows steady momentum and operational strength, while analysts maintain bullish sentiment and see further upside ahead.
Kiplinger · Feb 25 Health Care Stocks Have Sagged. Can You Bet on a Recovery? The flagging health care sector has perked up a bit lately. Is it time to invest?
Barchart · Feb 10 Stock Index Futures Muted With U.S. Retail Sales Data in Focus March S&P 500 E-Mini futures (ESH26) are up +0.03%, and March Nasdaq 100 E-Mini futures (NQH26) are up +0.04% this morning, taking a breather after a recent rally as investors await a slew of U.S. economic data, with particular attention on the retail sales report, remarks from Federal Reserve officials,…
Barchart · Jan 30 Should You Buy the Dip in These 2 Dividend Stocks? Tighter Medicare Advantage payment rates are testing two established health insurers, with CVS Health offering a safer dividend entry at 28% upside and 3% yield while Humana's 36% year-over-year decline creates a riskier but potentially stronger bounce-back opportunity if profitability stabilizes faster than the market expects.
Barchart · Jan 27 Are Wall Street Analysts Predicting CVS Health Stock Will Climb or Sink? As CVS Health has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.